Effect of creatinine and cystatin C measurement variations on calculated estimated glomerular filtration rate variations and the theoretical impact on kidney disease stage classification: A retrospective study.
The estimated glomerular filtration rate (eGFR) is an important parameter in the management of patients with kidney diseases, yet eGFR quality goals are lacking. We examined the uncertainties in eGFR determinations and assessed their impact on patient classifications, aiming to set eGFR quality goals. Adult patients undergoing creatinine concentration assessments at our hospital, between June 2014 and October 2016, were included (N=285,982). Using 7 eGFR equations, we calculated the imprecisions in the eGFR, based on the imprecisions in determining creatinine and/or cystatin C concentrations. The uncertainties in the eGFR were expressed as functions of creatinine and/or cystatin C concentration uncertainties. Subsequently, the number of ambiguous cases was assessed, based on the calculated uncertainty in the eGFR. Uncertainties in the eGFRs varied according to the eGFR calculation equation used. Although a 0.8% expanded uncertainty in the eGFR caused a 3.5% ambiguous case rate, a 10% expanded uncertainty resulted in a 42.3% rate of ambiguous cases. To meet minimal quality requirements, creatinine imprecision should be ≤3.0%. Even a low level of uncertainty in the eGFR may cause noticeable impacts on patient classifications. Laboratory physicians should be aware, and cautious, of the uncertainties in eGFR calculations.